secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2021-12-09T23:59:59+00:00
Accession:  0001683168-21-006223
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences stockholders approve director election, auditor ratification, equity plan increase
--------------------------------------------------------------------------------

- All seven director nominees elected; broker non-votes of 4,463,160 for each.
- Ratification of Marcum LLP as independent auditor for FY2021 approved: 7,554,719 for, 106,532 against.
- Advisory 'say-on-pay' resolution passed: 2,690,613 for, 472,665 against, 106,883 abstentions.
- Amendment to Equity Incentive Plan to increase authorized shares by 1,500,000 approved: 2,568,737 for, 670,987 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821006223/0001683168-21-006223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821006223/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-006223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer